524 related articles for article (PubMed ID: 16741370)
1. Residual renal function and volume control in peritoneal dialysis patients.
Cheng LT; Chen W; Tang W; Wang T
Nephron Clin Pract; 2006; 104(1):c47-54. PubMed ID: 16741370
[TBL] [Abstract][Full Text] [Related]
2. Salt and fluid intake in the development of hypertension in peritoneal dialysis patients.
Chen W; Cheng LT; Wang T
Ren Fail; 2007; 29(4):427-32. PubMed ID: 17497464
[TBL] [Abstract][Full Text] [Related]
3. Fluid state and blood pressure control: no differences between APD and CAPD.
Cnossen TT; Konings CJ; Fagel WJ; van der Sande FM; van Geel K; Leunissen KM; Kooman JP
ASAIO J; 2012; 58(2):132-6. PubMed ID: 22370683
[TBL] [Abstract][Full Text] [Related]
4. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients.
Wang X; Axelsson J; Lindholm B; Wang T
Blood Purif; 2005; 23(5):373-8. PubMed ID: 16088105
[TBL] [Abstract][Full Text] [Related]
5. Potassium metabolism in continuous ambulatory peritoneal dialysis patients.
Yu HL; Lu XH; Su CY; Tang W; Wang T
Ren Fail; 2014 Jun; 36(5):748-54. PubMed ID: 24512377
[TBL] [Abstract][Full Text] [Related]
6. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of furosemide in patients on peritoneal dialysis.
Flinn A; Ledger S; Blake P
CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
[TBL] [Abstract][Full Text] [Related]
8. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function.
Wang AY; Woo J; Wang M; Sea MM; Sanderson JE; Lui SF; Li PK
Nephrol Dial Transplant; 2005 Feb; 20(2):396-403. PubMed ID: 15187196
[TBL] [Abstract][Full Text] [Related]
9. Relationship between malnutrition-inflammation syndrome and ultrafiltration volume in continuous ambulatory peritoneal dialysis patients.
Tinroongroj N; Jittikanont S; Lumlertgul D
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S94-100. PubMed ID: 22043574
[TBL] [Abstract][Full Text] [Related]
10. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
[TBL] [Abstract][Full Text] [Related]
11. Salt intake and hypervolemia in the development of hypertension in peritoneal dialysis patients.
Inal S; Erten Y; Akbulu G; Oneç K; Tek NA; Sahin G; Okyay GU; Sanlier N
Adv Perit Dial; 2012; 28():10-5. PubMed ID: 23311206
[TBL] [Abstract][Full Text] [Related]
12. The effect of peritoneal dialysis method on residual renal function in children.
Roszkowska-Blaim M; Skrzypczyk P; Jander A; Tkaczyk M; Bałasz-Chmielewska I; Zurowska A; Drozdz D; Pietrzyk JA
Adv Perit Dial; 2012; 28():112-9. PubMed ID: 23311226
[TBL] [Abstract][Full Text] [Related]
13. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications?
Wang AY; Woo J; Sea MM; Law MC; Lui SF; Li PK
Am J Kidney Dis; 2004 Apr; 43(4):712-20. PubMed ID: 15042549
[TBL] [Abstract][Full Text] [Related]
14. Association between arterial stiffness and peritoneal fluid kinetics.
Zhe XW; Tian XK; Chen W; Guo LJ; Gu Y; Chen HM; Tang LJ; Wang T
Am J Nephrol; 2008; 28(1):128-32. PubMed ID: 17943019
[TBL] [Abstract][Full Text] [Related]
15. Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study.
Kim S; Oh J; Kim S; Chung W; Ahn C; Kim SG; Oh KH
Nephrol Dial Transplant; 2009 Sep; 24(9):2899-908. PubMed ID: 19258384
[TBL] [Abstract][Full Text] [Related]
16. Volume control in peritoneal dialysis patients guided by bioimpedance spectroscopy assessment.
Luo YJ; Lu XH; Woods F; Wang T
Blood Purif; 2011; 31(4):296-302. PubMed ID: 21242684
[TBL] [Abstract][Full Text] [Related]
17. Metabolic acidosis in peritoneal dialysis patients: the role of residual renal function.
Tian XK; Shan YS; Zhe XW; Cheng LT; Wang T
Blood Purif; 2005; 23(6):459-65. PubMed ID: 16244471
[TBL] [Abstract][Full Text] [Related]
18. Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment.
Ortega LM; Materson BJ
J Am Soc Hypertens; 2011; 5(3):128-36. PubMed ID: 21459067
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients.
Wong PN; Mak SK; Lo KY; Tong GM; Wong AK
Singapore Med J; 2004 Nov; 45(11):520-4. PubMed ID: 15510323
[TBL] [Abstract][Full Text] [Related]
20. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
